Tariquidar
![]() | |
Clinical data | |
---|---|
ATC code | none |
Identifiers | |
| |
CAS Number |
206873-63-4 ![]() |
PubChem (CID) | 148201 |
ChemSpider |
130650 ![]() |
UNII |
J58862DTVD ![]() |
ChEMBL |
CHEMBL348475 ![]() |
Chemical and physical data | |
Formula | C38H38N4O6 |
Molar mass | 646.73 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
![]() ![]() |
Tariquidar (INN/USAN) is a P-glycoprotein inhibitor[1] undergoing research as an adjuvant against multidrug resistance in cancer.
References
- ↑ Robey RW, Shukla S, Finley EM, Oldham RK, Barnett D, Ambudkar SV, Fojo T, Bates SE. Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)). Biochem Pharmacol 2008;3:1302-12. PMID 18234154.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.